Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · Real-Time Price · USD
2.160
-0.190 (-8.09%)
At close: Apr 1, 2025, 4:00 PM
2.270
+0.110 (5.11%)
After-hours: Apr 1, 2025, 4:47 PM EDT
Lisata Therapeutics Market Cap
Lisata Therapeutics has a market cap or net worth of $18.16 million as of April 1, 2025. Its market cap has decreased by -27.92% in one year.
Market Cap
18.16M
Enterprise Value
-11.35M
1-Year Change
-27.92%
Ranking
Category
Stock Price
$2.16
Market Cap Chart
Since March 1, 1999, Lisata Therapeutics's market cap has increased from $500.00K to $18.16M, an increase of 3,532.62%. That is a compound annual growth rate of 14.76%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Mar 31, 2025 | 20.30M | -18.80% |
Dec 31, 2024 | 25.00M | 12.61% |
Dec 29, 2023 | 22.20M | 11.56% |
Dec 30, 2022 | 19.90M | -60.44% |
Dec 31, 2021 | 50.30M | 81.59% |
Dec 31, 2020 | 27.70M | 6.13% |
Dec 31, 2019 | 26.10M | -25.43% |
Dec 31, 2018 | 35.00M | 5.42% |
Dec 29, 2017 | 33.20M | 43.72% |
Dec 30, 2016 | 23.10M | -61.37% |
Dec 31, 2015 | 59.80M | -55.61% |
Dec 31, 2014 | 134.70M | -27.23% |
Dec 31, 2013 | 185.10M | 93.62% |
Dec 31, 2012 | 95.60M | 74.77% |
Dec 30, 2011 | 54.70M | -32.64% |
Dec 31, 2010 | 81.20M | 43.46% |
Dec 31, 2009 | 56.60M | 1,564.71% |
Dec 31, 2008 | 3.40M | -46.03% |
Dec 31, 2007 | 6.30M | -57.14% |
Dec 29, 2006 | 14.70M | 226.67% |
Dec 30, 2005 | 4.50M | 87.50% |
Dec 31, 2004 | 2.40M | -42.86% |
Dec 31, 2003 | 4.20M | 366.67% |
Dec 31, 2002 | 900.00K | -90.22% |
Dec 31, 2001 | 9.20M | 29.58% |
View and export this data all the way back to 1999.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 738.61B |
UnitedHealth Group | 472.03B |
Johnson & Johnson | 394.52B |
AbbVie | 363.15B |
Novo Nordisk | 305.46B |
AstraZeneca | 229.16B |
Abbott Laboratories | 226.88B |
Merck & Co. | 225.40B |